Telomir Pharmaceuticals, Inc. Common Stock Stock Analysis & AI Score
Telomir Pharmaceuticals, Inc. Common Stock (TELO) has an ST Score of 48.9 (C+), driven by its Financial Strength (A+) and held back by its Profitability (F). TELO last traded at $1.21.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Telomir Pharmaceuticals, Inc. Common Stock (TELO) has an ST Score of 48.9 (C+), driven by its Financial Strength (A+) and held back by its Profitability (F). TELO last traded at $1.21.
- Strongest
- Financial StrengthA+
- Weakest
- ProfitabilityF
All factor grades
- Financial StrengthA+
- ForecastA
- MomentumB+
- ValuationC
- GrowthC-
- ProfitabilityF
- Piotroski2/9
Contact
TELO stock: frequently asked questions
What is TELO's ST Score?
Telomir Pharmaceuticals, Inc. Common Stock (TELO) has an ST Score of 48.9 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is TELO a buy, hold, or sell?
Our ST Score grades it C+ (48.9/100). The ST Score is a data-driven signal, not a recommendation.
What are TELO's factor grades?
Valuation C, Profitability F, Financial Strength A+, Momentum B+, Growth C-, Forecast A.
What is TELO's valuation grade?
Telomir Pharmaceuticals, Inc. Common Stock (TELO) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is TELO's growth grade?
Telomir Pharmaceuticals, Inc. Common Stock (TELO) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is TELO's profitability grade?
Telomir Pharmaceuticals, Inc. Common Stock (TELO) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is TELO's financial strength grade?
Telomir Pharmaceuticals, Inc. Common Stock (TELO) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for TELO?
The average analyst price target for Telomir Pharmaceuticals, Inc. Common Stock (TELO) is $4.00, which is +230.6% versus the recent price of $1.21.
What is TELO's Piotroski score?
Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.